Hostname: page-component-77c89778f8-rkxrd Total loading time: 0 Render date: 2024-07-24T00:32:06.307Z Has data issue: false hasContentIssue false
  • English
  • Français

Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia

Published online by Cambridge University Press:  09 July 2009

P. R. Dunbar ,
J. Hill ,
T. J. Neale  and
G. W. Mellsop
P. R. Dunbar*
Affiliation:
Departments of Medicine and Psychological Medicine, Wellington School of Medicine, Wellington, New Zealand
J. Hill
Affiliation:
Departments of Medicine and Psychological Medicine, Wellington School of Medicine, Wellington, New Zealand
T. J. Neale
Affiliation:
Departments of Medicine and Psychological Medicine, Wellington School of Medicine, Wellington, New Zealand
G. W. Mellsop
Affiliation:
Departments of Medicine and Psychological Medicine, Wellington School of Medicine, Wellington, New Zealand
*
1 Address for correspondence: Dr P. R. Dunbar, Department of Medicine, Wellington School of Medicine, PO Box 7343, Wellington South, New Zealand.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Neopterin is a validated marker of the activation of cell-mediated immunity in a variety of disease states. We measured neopterin and creatinine concentrations in the plasma and urine of 22 schizophrenic and 26 depressed patients admitted acutely to hospital, and compared results with those in a large group of normal controls. Neopterin/creatinine ratios were normal in the schizophrenic patients, but significantly elevated in the plasma of depressed patients. In each diagnostic group, the use of psychotropic drugs before admission had no effect on the neopterin ratios observed. Our findings indicate altered cell-mediated immunity in depression.

Type
Brief Communication
Information
Psychological Medicine , Volume 22 , Issue 4 , November 1992 , pp. 1051 - 1057
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

APA (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. revised. American Psychiatric Association: Washington.Google Scholar
Coppen, A., Swade, C., Jones, S. A., Armstrong, R. A., Blair, J. A. & Leeming, R. J. (1989). Depression and tetrahydrobiopterin: the folate connection. Journal of Affective Disorders 16, 103–107.CrossRefGoogle ScholarPubMed
Duch, D. S., Woolf, J. H., Nichol, C. A., Davidson, J. R. & Garbutt, J. C. (1984). Urinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatry Research 11, 83–89.CrossRefGoogle ScholarPubMed
Editorial (1988). Neopterin in clinical medicine. Lancet i, 509–511.Google Scholar
Fahey, J. L., Taylor, J. M., Detels, R., Hofmann, B., Melmed, R., Nishanian, P. & Giorgi, J. V. (1990). The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. New England Journal of Medicine 322, 166–172.CrossRefGoogle ScholarPubMed
Fessel, W. J. (1962 a). Blood proteins in functional psychoses. Archives of General Psychiatry 6, 132–148.CrossRefGoogle ScholarPubMed
Fessel, W. J. (1962 b). Autoimmunity and mental illness. Archives of General Psychiatry 6, 320–323.CrossRefGoogle ScholarPubMed
Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Dierich, M. P. & Wachter, H. (1988). Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunology Today 9, 150–155.CrossRefGoogle ScholarPubMed
Hausen, A., Fuchs, D., Konig, K. & Wachter, H. (1982). Determination of neopterin in urine by reversed-phase high performance liquid chromatography. Journal of Chromatography 227, 61–70.CrossRefGoogle ScholarPubMed
Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Long, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J. & Wachter, H. (1984). Immune response-associated production of neopterin. Journal of Experimental Medicine 160, 310–316.CrossRefGoogle ScholarPubMed
Huxley, J., Mayr, E. & Osmond, H. (1964). Schizophrenia as a genetic morphism. Nature 20, 220–221.CrossRefGoogle Scholar
Khansari, D. N., Murgo, A. J. & Faith, R. E. (1990). Effects of stress on the immune system. Immunology Today 11, 170–175.CrossRefGoogle ScholarPubMed
King, D. J. & Cooper, S. J. (1989). Viruses, immunity and mental disorder. British Journal of Psychiatry 154, 1–7.CrossRefGoogle ScholarPubMed
Kronfol, Z., Silva, J., Greden, J., Dembinski, S., Gardney, R. & Carroll, B. (1983). Impaired lymphocyte function in depressive illness. Life Sciences 33, 241–247.CrossRefGoogle ScholarPubMed
Lacronique, J., Auzeby, A., Valeyre, D., Traore, B. M., Barbosa, M. L. A., Soler, P., Coudat, D., Mattesti, J. P., Touitou, Y. & Marsac, J. (1989). Urinary neopterin in pulmonary sarcoidosis. American Review of Respiratory Disease 139, 1474–1478.CrossRefGoogle ScholarPubMed
Maes, M., Bosmans, E., Suy, E., Minner, B. & Raus, J. (1989).Impaired lymphocyte stimulation by mitogens in severely depressed patients. British Journal of Psychiatry 155, 793–798.CrossRefGoogle Scholar
Mellsop, G., Whittingham, S. & Ungar, B. (1973). Schizophrenia and autoimmune serological reactions. Archives of General Psychiatry 28, 194–196.CrossRefGoogle ScholarPubMed
Mellsop, G. W., Koadlow, L. & Syme, J. (1974). Absence of rheumatoid arthritis in schizophrenia. Australia and New Zealand Journal of Medicine 4, 247–252.CrossRefGoogle ScholarPubMed
Mellsop, G. W., Thomas, C. S. & Ellis, P. M. (1991). The reliability of the draft diagnostic criteria for research of ICD-10 and DSM-III-R. Acta Psychiatrica Scandinavica 84, 332–335.CrossRefGoogle ScholarPubMed
Moss, A. R. (1988). Predicting who will progress to AIDS. British Medical Journal 297, 1067–1068.CrossRefGoogle ScholarPubMed
Neale, T. J., Hill, J. H., Cooke, R. & Dunbar, P. R. (1990). Neopterin quantitation indicates participation of cell mediated immunity(CMI) in human glomerulonephritis (GN). Kidney International 37, 442.Google Scholar
Neale, T. J., Windom, H. H., Hill, J., Dunbar, P. R., Cook, R., Crane, J. & Beasley, R. (1991). Neopterin quantification in acute severe asthma. Clinical and Experimental Allergy 21, 417–424.CrossRefGoogle ScholarPubMed
O'Donnell, M., Silove, D. & Wakefield, D. (1988). Current perspectives on immunology and psychiatry. Australian and New Zealand Journal of Psychiatry 22, 366–382.CrossRefGoogle ScholarPubMed
Prior, C., Hausen, A., Reibnegger, G., Vogel, W., Fuchs, D., Judmaier, G., Werner, E. R. & Wachter, H. (1987). Potential of urinary neopterin excretion in differentiating chronic non-A, non-B hepatitis from fatty liver. Lancet ii, 1235–1237.CrossRefGoogle Scholar
Reibnegger, G., Aulitzky, W. & Huber, C. (1986 a). Neopterin in urine and serum of renal allograft recipients. Journal of Clinical Chemistry and Clinical Biochemistry 24, 770–779.Google Scholar
Reibnegger, G. J., Bichler, A. H., Dapunt, O., Fuchs, D. N., Fruith, L. C., Hausen, A., Hetzel, H. M., Lutz, H., Werner, E. R. & Wachter, H. (1986 b). Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Research 46, 950–955.Google ScholarPubMed
Reibnegger, G., Egg, D. & Fuchs, D. (1986 c). Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Arthritis and Rheumatism 29, 1063–1070.CrossRefGoogle ScholarPubMed
Schafer, A. J., Baniel, V., Dreikorn, K. & Opelz, G. (1986). Assessment of plasma neopterin in clinical kidney transplantation. Transplantation 41, 454–459.CrossRefGoogle ScholarPubMed
Schindler, B. A. (1985). Stress, affective disorders and immune function. Medical Clinics of North America 69, 585–597.CrossRefGoogle ScholarPubMed
Schleifer, S. J., Keller, S. E., Bond, R. N., Cohen, J. & Stein, M. (1989). Major depressive disorder and immunity. Archives of General Psychiatry 46, 81–87.CrossRefGoogle ScholarPubMed
Sperner-Unterweger, B., Barnas, C., Fleischhacker, W. W., Fuchs, D., Meise, U., Reibnegger, G. & Wachter, H. (1989). Is schizophrenia linked to alteration in cellular immunity? Schizophrenia Research 2, 17–21.CrossRefGoogle ScholarPubMed
Stein, M. (1989). Stress, depression and the immune system. Journal of Clinical Psychiatry 50, 5(Suppl.), 35–42.Google ScholarPubMed
Wachter, H., Fuchs, D., Hausen, A., Reibnegger, G. & Werner, E. R. (1989). Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Advances in Clinical Chemistry 27, 81–141.CrossRefGoogle ScholarPubMed
Werner, E. R., Bichler, A., Daxenbichler, G., Fuchs, D., Fruith, L. C., Hausen, A., Hetzel, H., Reibnegger, G., Wachter, H. (1987). Determination of neopterin in serum and urine. Clinical Chemistry 33, 62–66.CrossRefGoogle ScholarPubMed